HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (19) Citing Articles via Google Scholar Google Scholar Articles by Chagin, A S Articles by Sävendahl, L Search for Related Content PubMed PubMed Citation Articles by Chagin, A S Articles by Sävendahl, L

¹ Pediatric Endocrinology Unit, Department of Woman and Child Health, Karolinska Institute, Karolinska University Hospital, SE-171 76 Stockholm, Sweden
² Department of Biochemistry and Molecular Dentistry, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan

(Requests for offprints should be addressed to A S Chagin; Email: andrei.chagin{at}ki.se)

The importance of estrogens for the regulation of longitudinal bone growth is unequivocal. However, any local effect of estrogens in growth plate cartilage has been debated. Recently, several enzymes essential for estrogen synthesis were shown to be expressed in rat growth plate chondrocytes. Local production of 17ß-estradiol (E2) has also been demonstrated in rat costal chondrocytes. We aimed to determine the functional role of locally produced estrogen in growth plate cartilage. The human chondrocyte-like cell line HCS-2/8 was used to study estrogen effects on cell proliferation (³H-labeled thymidine uptake) and apoptosis (cell death detection ELISA kit). Chondrocyte production of E2 was measured by RIA and organ cultures of fetal rat metatarsal bones were used to study the effects of estrogen on longitudinal growth rate. We found that significant amounts of E2 were produced by HCS-2/8 chondrocytes (64.1 ± 5.3 fmol/3 days/10⁶cells). The aromatase inhibitor letrozole (1 µM) and the pure estrogen receptor antagonist ICI 182,780 (10 µM) inhibited proliferation of HCS-2/8 chondrocytes by 20% (P<0.01) and almost 50% (P<0.001), respectively. Treatment with ICI 182,780 (10 µM) increased apoptosis by 228% (P<0.05). Co-treatment with either caspase-3 or pan-caspase inhibitors completely blocked ICI 182,780-induced apoptosis (P<0.001 vs ICI 182,780 only). Moreover, both ICI 182,780 (10 µM) and letrozole (1 µM) decreased longitudinal growth of fetal rat metatarsal bones after 7 days of culture (P<0.01). In conclusion, our data clearly show that chondrocytes endogenously produce E2 and that locally produced estrogen stimulates chondrocyte proliferation and protects from spontaneous apoptosis. In addition, longitudinal growth is promoted by estrogens locally produced within the epiphyseal growth plate.

This article has been cited by other articles:

				E. Lindahl, U. Nyman, F. Zaman, C. Palmberg, A. Cascante, J. Shafqat, M. Takigawa, L. Savendahl, H. Jornvall, and B. Joseph Proinsulin C-peptide Regulates Ribosomal RNA Expression J. Biol. Chem., January 29, 2010; 285(5): 3462 - 3469. [Abstract] [Full Text] [PDF]

				A. S Chagin, E. Karimian, K. Sundstrom, E. Eriksson, and L. Savendahl Catch-up growth after dexamethasone withdrawal occurs in cultured postnatal rat metatarsal bones J. Endocrinol., January 1, 2010; 204(1): 21 - 29. [Abstract] [Full Text] [PDF]